Oxidosqualene Cyclase from Saccharomyces Cerevisiae, Trypanosoma Cruzi, Pneumocystis Carinii and Arabidopsis Thaliana Expressed in Yeast: a Model for the Development of Novel Antiparasitic Agents

A series of 25 compounds, some of which previously were described as inhibitors of human liver microsomal oxidosqualene cyclase (OSC), were tested as inhibitors of Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana OSCs expressed in an OSC-defective strain of S. cerevisiae. The screening identified three derivatives particularly promising for the development of novel anti-Trypanosoma agents and eight derivatives for the development of novel anti-Pneumocystis agents.